When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Cholestatic pruritus - Wikipedia

   en.wikipedia.org/wiki/Cholestatic_pruritus

   Cholestatic pruritus is the sensation of itch due to nearly any liver disease, but the most commonly associated entities are primary biliary cholangitis, primary sclerosing cholangitis, obstructive choledocholithiasis, carcinoma of the bile duct, cholestasis (also see drug-induced pruritus), and chronic hepatitis C viral infection and other forms of viral hepatitis.

3. Primary biliary cholangitis - Wikipedia

   en.wikipedia.org/wiki/Primary_biliary_cholangitis

   Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. [1] [2] [3] It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis.

4. US FDA approves expanded use of Mirum's liver disease drug - AOL

   www.aol.com/news/us-fda-approves-expanded-mirums...

   (Reuters) -The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals' oral drug to treat itching caused by a liver disorder in patients aged five years and older ...

5. Primary sclerosing cholangitis - Wikipedia

   en.wikipedia.org/wiki/Primary_sclerosing_cholangitis

   No effective medical treatment for primary sclerosing cholangitis is known. Its most definitive treatment is a liver transplant, [1] but disease recurrence can occur in 25–30% of cases. [6] PSC is a rare disease and most commonly affects people with IBD. [2]

6. Cholestasis - Wikipedia

   en.wikipedia.org/wiki/Cholestasis

   Possible treatment options include antihistamines, ursodeoxycholic acid, and phenobarbital. Nalfurafine hydrochloride can also be used to treat pruritus caused by chronic liver disease and was recently approved in Japan for this purpose. [117] Bile acid binding resins like cholestyramine are the most common treatment. Side effects of this ...

7. Gilead gets US FDA approval for inflammatory liver disease drug

   www.aol.com/news/us-fda-approves-gileads-liver...

   The disease, primary biliary cholangitis (PBC), causes inflammation of the small bile ducts in the liver and can eventually destroy them. Rival drug, Iqirvo, from Ipsen costs $11,500 per month.